Molecular Therapy — Nucleic Acids · 2020 · 77 citations · 50 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyOncogenesNoncoding Rna BiologyNoncoding Rna In CancerRna InterferenceRna-binding ProteinsTranscription Factor OncogenesTumor Suppressor GenesLong Non-coding Ribonucleic AcidsLong Noncoding Rna DysregulationLong Noncoding Rna RegulationMalignant ProgressionMrna Stability Regulation By Noncoding RnaNoncoding Rna StabilityNoncoding Rna-mediated Gene RegulationProtein Expression Levels
and S-phase expressed 1 (GTSE1) was identified as an oncogene in glioma, and knockdown of MTF1 or YY2 decreased the mRNA and protein expression levels of GTSE1 through direct binding to the GTSE1 promoter region. Our study highlights a key role of the TAF15/LINC00665/MTF1(YY2)/GTSE1 axis in modulating the malignant biological behaviors of glioma cells, suggesting novel mechanisms by which lncRNAs affect STAU1-mediated mRNA stability, which can inform new molecular therapies for glioma.
50
Mammalian Staufen1 Recruits Upf1 to Specific mRNA 3′UTRs so as to Elicit mRNA Decay
Yoon Ki Kim, Luc Furic, Luc DesGroseillers et al. · Cell · 2005 · 501 citations · Full text
Mattias K. Andersson, Anders Ståhlberg, Yvonne Arvidsson et al. · BMC Cell Biology · 2008 · 339 citations · Full text
Micropeptide CIP2A‐BP encoded by LINC00665 inhibits triple‐negative breast cancer progression
Binbin Guo, Siqi Wu, Xun Zhu et al. · The EMBO Journal · 2019 · 240 citations · Full text